Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy

被引:205
作者
Wang, S
Chen, Q
Simon, TC
Strebeck, F
Chaudhary, L
Morrissey, J
Liapis, H
Klahr, S
Hruska, KA
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[4] Beijing Med Univ, Div Renal, Hosp 3, Beijing, Peoples R China
基金
美国国家卫生研究院;
关键词
BMP-7; diabetic nephropathy; chronic kidney disease;
D O I
10.1046/j.1523-1755.2003.00035.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background. Bone morphogenic protein-7 (BMP-7), an essential developmental renal morphogen, is a secreted differentiation factor of the adult collecting duct. It activates receptors in the collecting duct, distal nephron, proximal tubule, and glomerulus. BMP-7 is therapeutic in tubulointerstitial nephritis raising the question of broader efficacy in chronic kidney disease (CKD). Methods. Diabetes was induced in 200 g rats by a single dose of streptozotocin. After 16 weeks, glomerular hypertrophy and proteinuria were established, and therapy with BMP-7 (10, 30, or 100 mug/kg intravenously twice a week), enalapril (20 mg/kg), or vehicle was begun and continued until 32 weeks. Kidney weight, glomerular filtration rate (GFR), urine albumin excretion, blood pressure, pathology, and BMP-7 expression were measured. Results. Diabetic vehicle-treated rats developed renal insufficiency by 32 weeks (GFR, 0.34+/-0.02 mL/min/100 g body weight vs. 0.55+/-0.02 in normal). In the diabetic BMP-7 high-dose-treated rats, GFR was preserved (0.70+/-0.08, P<0.01 vs. vehicle), and higher than diabetic enalapril-treated rats (0.58+/-0.06). Kidney weights of vehicle-treated animals were not affected, but were reduced in all of the treatment groups (P<0.001). Proteinuria was reversed to normal by BMP-7 in a dose-dependent manner. The reduction in proteinuria by the intermediate dose of BMP-7 was similar to the effect of enalapril therapy. Glomerular area and interstitial volume were significantly decreased in the BMP-7 and enalapril-treated animals. Glomerular sclerosis was prevented by BMP-7 therapy more effectively than by enalapril. Enalapril controlled hypertension throughout the course of therapy while BMP-7 did not affect blood pressure until the final 4 weeks of therapy. Diabetic vehicle-treated rats lost BMP-7 expression in the kidney. BMP-7 and enalapril therapy restored BMP-7 expression at high levels. Conclusion. BMP-7 partially reversed diabetic-induced kidney hypertrophy, restoring GFR, urine albumin excretion, and glomerular histology toward normal. Restoration of BMP-7 expression was associated with a successful repair reaction and a reversal of the ill-fated injury response.
引用
收藏
页码:2037 / 2049
页数:13
相关论文
共 37 条
[1]
SHORT AND LONG-TERM EFFECTS OF ANTIHYPERTENSIVE THERAPY IN THE DIABETIC RAT [J].
ANDERSON, S ;
RENNKE, HG ;
GARCIA, DL ;
BRENNER, BM .
KIDNEY INTERNATIONAL, 1989, 36 (04) :526-536
[2]
DAVIES MR, IN PRESS J AM SOC NE
[3]
Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO
[4]
2-M
[5]
A REQUIREMENT FOR BONE MORPHOGENETIC PROTEIN-7 DURING DEVELOPMENT OF THE MAMMALIAN KIDNEY AND EYE [J].
DUDLEY, AT ;
LYONS, KM ;
ROBERTSON, EJ .
GENES & DEVELOPMENT, 1995, 9 (22) :2795-2807
[6]
BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells [J].
Gould, SE ;
Day, M ;
Jones, SS ;
Dorai, H .
KIDNEY INTERNATIONAL, 2002, 61 (01) :51-60
[7]
MORPHOGENETIC INTERACTION BETWEEN EMBRYONIC MOUSE TISSUES SEPARATED BY A MEMBRANE FILTER [J].
GROBSTEIN, C .
NATURE, 1953, 172 (4384) :869-871
[8]
The renal expression of transforming growth factor-β isoforms and their receptors in acute and chronic experimental diabetes in rats [J].
Hill, C ;
Flyvbjerg, A ;
Gronbæk, H ;
Petrik, J ;
Hill, DJ ;
Thomas, CR ;
Sheppard, MC ;
Logan, A .
ENDOCRINOLOGY, 2000, 141 (03) :1196-1208
[9]
Smad7-dependent regulation of heme oxygenase-1 by transforming growth factor-β in human renal epithelial cells [J].
Hill-Kapturczak, N ;
Truong, L ;
Thamilselvan, V ;
Visner, GA ;
Nick, HS ;
Agarwal, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :40904-40909
[10]
Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction [J].
Hruska, KA ;
Guo, GJ ;
Wozniak, M ;
Martin, D ;
Miller, S ;
Liapis, H ;
Loveday, K ;
Klahr, S ;
Sampath, TK ;
Morrissey, J .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (01) :F130-F143